Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Viridian Therapeutics, Inc.
Business Segments
Business Segments
Business Segments
6 metrics
Segment research and development expense
Segment selling, general and administrative expense
Total share-based compensation expense
Operating Expenses
Other items
Net loss
Watchlist
Screener
Filings
Earnings
Charts